Synairgen - a drug discovery company specialising in respiratory diseases with a focus on asthma and chronic obstructive pulmonary disease (COPD)

Synairgen is
a respiratory drug development company with a particular focus
on lung antiviral defence in asthma, COPD and severe viral infections

Click above to open the London Stock Exchange website for the latest share price information
More

Copies of our Report and Accounts can be found here
More

Find out more about Synairgen, its Directors and Founders
More